Description
The Anti-dsDNA IgG assay serves as a primary diagnostic tool for Systemic Lupus Erythematosus (SLE) and aids in distinguishing it from related conditions. According to the American College of Rheumatology (ACR), detecting autoantibodies targeting dsDNA, along with elevated antinuclear antibody (ANA) titers, constitutes a core criterion for diagnosing SLE. Furthermore, quantifying these antibody levels provides valuable clinical insights for assessing therapeutic efficacy and forecasting potential disease flare-ups